Covid-19 roundup: CDC recommends mRNA vaccines over J&J’s due to rare blood clots; EU considers deal for variant-specific doses of Pfizer/BioNTech vaccine
The CDC has officially recommended that Americans receive one of the mRNA vaccines over J&J’s single-dose vaccine due to renewed concerns about rare but sometimes fatal blood clots.
The decision followed a unanimous vote by the Advisory Committee on Immunization Practices (ACIP) to recommend against taking J&J’s shot, if either the Pfizer/BioNTech or Moderna shot is available. J&J’s vaccine will still be available to those who are unable or unwilling to get an mRNA vaccine.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters
